EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age

George Du Toit, Kari R Brown, Andrea Vereda, Anne-Marie Irani, Stephen Tilles, Anoshie Ratnayake, Stacie M Jones, Brian P Vickery

NEJM Evidence · 24.10.2023 · 2 (11)

DOI: 10.1056/evidoa2300145 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 24.10.2023. Verfasst von George Du Toit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guy's and St. Thomas' National Health Service Foundation Trust and Kings College, London. Hauptthemen laut MEDLINE: Peanut Hypersensitivity. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Peanut allergy is a common childhood allergy, and the only approved treatment for children 4 to 17 years of age is peanut allergen powder-dnfp (PTAH) oral immunotherapy. METHODS: For this phase 3, randomized, double-blind, placebo-controlled trial, we enrolled peanut-allergic children 1 to

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peanut HypersensitivityChildHumansAdministration, OralAllergensArachisDesensitization, ImmunologicDouble-Blind Method

Substanzen

Allergens

Autor:innen und Institutionen

  • Guy's and St. Thomas' National Health Service Foundation Trust and Kings College, London.
  • Aimmune Therapeutics, Nestlé Health Science, Brisbane, CA.
  • Aimmune Therapeutics, Nestlé Health Science, London.
  • University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock.
  • Emory University School of Medicine, Atlanta.

Zitieren

APA

Du Toit, G., Brown, K. R., Vereda, A., Irani, A. M., Tilles, S., Ratnayake, A., Jones, S. M., & Vickery, B. P. (2023). Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age. NEJM Evidence, 2(11). https://doi.org/10.1056/evidoa2300145

Vancouver

Du Toit G, Brown KR, Vereda A, Irani AM, Tilles S, Ratnayake A, et al. Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age. NEJM Evidence. 2023;2(11). doi:10.1056/evidoa2300145

BibTeX
@article{DuToit2023,
  author = {Du Toit, George and Brown, Kari R and Vereda, Andrea and Irani, Anne-Marie and Tilles, Stephen and Ratnayake, Anoshie and Jones, Stacie M and Vickery, Brian P},
  title = {Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age},
  journal = {NEJM Evidence},
  year = {2023},
  volume = {2},
  number = {11},
  doi = {10.1056/evidoa2300145}
}
Kostenlos starten →